Arafat, M.; Fouladian, P.; Wignall, A.; Song, Y.; Parikh, A.; Albrecht, H.; Prestidge, C.A.; Garg, S.; Blencowe, A.
Development and In Vitro Evaluation of 5-Fluorouracil-Eluting Stents for the Treatment of Colorectal Cancer and Cancer-Related Obstruction. Pharmaceutics 2021, 13, 17.
https://doi.org/10.3390/pharmaceutics13010017
AMA Style
Arafat M, Fouladian P, Wignall A, Song Y, Parikh A, Albrecht H, Prestidge CA, Garg S, Blencowe A.
Development and In Vitro Evaluation of 5-Fluorouracil-Eluting Stents for the Treatment of Colorectal Cancer and Cancer-Related Obstruction. Pharmaceutics. 2021; 13(1):17.
https://doi.org/10.3390/pharmaceutics13010017
Chicago/Turabian Style
Arafat, Mohammad, Paris Fouladian, Anthony Wignall, Yunmei Song, Ankit Parikh, Hugo Albrecht, Clive A. Prestidge, Sanjay Garg, and Anton Blencowe.
2021. "Development and In Vitro Evaluation of 5-Fluorouracil-Eluting Stents for the Treatment of Colorectal Cancer and Cancer-Related Obstruction" Pharmaceutics 13, no. 1: 17.
https://doi.org/10.3390/pharmaceutics13010017
APA Style
Arafat, M., Fouladian, P., Wignall, A., Song, Y., Parikh, A., Albrecht, H., Prestidge, C. A., Garg, S., & Blencowe, A.
(2021). Development and In Vitro Evaluation of 5-Fluorouracil-Eluting Stents for the Treatment of Colorectal Cancer and Cancer-Related Obstruction. Pharmaceutics, 13(1), 17.
https://doi.org/10.3390/pharmaceutics13010017